OrganiGram Holdings Stock (TSXV: OGI) (NASDAQ: OGI) - Investor Dashboard

➔ OrganiGram Holdings
TSX Venture Exchange: OGI
Sector: Healthcare
Industry: Consumer Products
Country: Canada
Employees: 705 at 07/15/19
Established: 2013
CEO: Greg Engel

OrganiGram Holdings – Cannabis Facilities

Midas Letter visits the state-of-the-art, purpose-built cannabis growing operation at Organigram Holdings.

  • Head office, three-level production facility and R&D located in Moncton, NB
  • Two buildings on 14 acres
  • 480,000 sq. ft. of production space at full build out
  • Fully funded expansion to increase capacity to 113,000 kilograms per year
  • Phase 4 expansion to include a state-of-the-art mechanical system and improved irrigation system; Construction expected to be completed by the end of 2019 for total capex of approximately $125M
  • Phase 5 expansion to include additional 56,000 square feet set aside for edibles, vaporizable products, and extraction; adding new harvesting, trim, drying, and processing rooms
  • Phase 5 construction slated for completion in October 2019; estimated capex of $48M
  • Lowest general corporate income tax in Atlantic Canada

Future Expansion of Moncton Campus

Visit OrganiGram Holdings

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. OrganiGram Holdings is a client of NCV Media, LLC. Read our full disclaimer.